Skip to content

Effect of Xushan Qingfei Mixture on chronic lung disease

Effect of Xueshan Qingfei Mixture on chronic lung disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004787
Enrollment
Unknown
Registered
2021-04-25
Start date
2021-04-26
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic lung disease

Interventions

Sponsors

Second Xiangya hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Moderate and severe COPD patients: according to the diagnostic criteria of COPD in the guidelines for diagnosis and treatment of COPD issued by GOLD 2019; 2.Sign informed consent; 3.No communication barrier, can cooperate with medical history collection, and good compliance, cooperate with treatment.

Exclusion criteria

Exclusion criteria: 1.Combined with other serious cardiopulmonary diseases, such as interstitial lung disease, severe asthma, severe pneumonia, tuberculosis, lung cancer, rheumatic heart disease, congenital heart disease, etc; 2.Patients with severe liver and kidney diseases; 3.Failure to use drugs according to regulations, inability to determine curative effect or incomplete information, etc. affect the judgment of curative effect or safety.

Design outcomes

Primary

MeasureTime frame
Inflammatory markers;Induced sputum;pulmonary function;

Countries

China

Contacts

Public ContactWu Shangjie

Second Xiangya Hospital of Central South University

wushangjie@csu.edu.cn+86 13607488688

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026